Drug Trial Radar · NCT07494305
Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE.
Last checked: Nov 19, 2026Latest source record: Jul 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
320
Planned (sponsor's estimate)
Start
Jan 23, 2026
Primary completion
Feb 2028
Study completion Feb 2028
Sponsor
- Lead sponsor
- LB Pharmaceuticals Inc.Industry
- Sponsor type
- Industry
- First posted
- Mar 27, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Phase II study for patients with Bipolar 1 Disorder experiencing major depressive episode. Patient eligible for enrollment will be randomized (like flipping a coin) to either active drug (LB-102 or placebo). Treatment is for 6 weeks.
Conditions
- Bipolar I Disorder
Interventions
LB-102Drug
N-methyl amisulpride
PlaceboOther
Inactive substance that looks identical to the active treatment
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline in Montgomery Åsberg Depression Rating -10 core symptom scale (MADRS-10)Time frame: Baseline to Day 42
Locations
26 sites in 1 country. Site status is shown where the registry gives one.
Pillar Clinical Research
Bentonville, Arkansas · Recruiting
Pillar Clinical Research
Little Rock, Arkansas · Recruiting
CenExel
Bellflower, California · Recruiting
ProScience Research Group
Culver City, California · Recruiting
CenExel
Garden Grove, California · Recruiting
Synergy San Diego
Lemon Grove, California · Recruiting
NRC Research Institute
Los Angeles, California · Recruiting
NRC Research Institute
Orange, California · Recruiting
CenExel
Riverside, California · Recruiting
CenExel
Torrance, California · Recruiting
St. Jude Clinical Research
Doral, Florida · Recruiting
Cenexel Hollywood Florida
Hollywood, Florida · Recruiting
Innovative Clinical Research
Miami Lakes, Florida · Recruiting
Health Synergy Clinical Research
West Palm Beach, Florida · Recruiting
Trialmed
Atlanta, Georgia · Recruiting
Cenexel Decatur GA
Decatur, Georgia · Recruiting
Pillar Clinical Research
Chicago, Illinois · Recruiting
NSRT
Detroit, Michigan · Recruiting
Arch Clinical Trials
St Louis, Missouri · Recruiting
Redbird Research
Las Vegas, Nevada · Recruiting
Manhattan Behavioral Medicine
New York, New York · Recruiting
Neuro-Behavioral Clinical Research
Canton, Ohio · Recruiting
Adams Clinical
Philadelphia, Pennsylvania · Recruiting
Adams Clinical
DeSoto, Texas · Recruiting
Pillar Clinical Research
Richardson, Texas · Recruiting
Northwest Clinical Research Center
Bellevue, Washington · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.